LabGenius combines artificial intelligence, robotic automation and synthetic biology to evolve next-generation protein therapeutics.

LabGenius develops therapeutics of high value for diseases of unmet need. The company deploys machine intelligence to model the relationship between DNA sequence and protein function, while improving the predictive accuracy of these models through experimental lab data generated through its smart robotic platform.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • James Field

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • As we take on new collaborations, we're delighted at the success of another lab expansion, which doubles our capaci… https://t.co/p0EvM1wCZu@labgeni_us - 11h
  • Multi-disciplinary collaboration makes the magic happen, and we recognise the importance of #InclusiveLeadership in… https://t.co/FcwCSlDijG@labgeni_us - 12:34 PM Jul 22nd
  • LabGenius' Founder and CEO, @jejfield 👨🏻‍💻, reflects on the positive impact that the @AblynxNV @sanofi partnership… https://t.co/uqNswtn4R6@labgeni_us - 11:30 AM Jul 16th